Why Is Clover Wellness (CLOV) Stock Up Today? Director Chelsea Clinton purchased 100,000 shares of CLOV stock 

Right now, shareholders of Clover Health (NASDAQ: CLOV) are smiling ear to ear. Although clov stock forecast remains down greater than 25% year-to-date (YTD), shares of the firm are up over 20% today.

Why exactly is Clover Health and wellness trading higher right now?

Over the weekend break, it was reported that Clover director Chelsea Clinton had actually recently acquired shares of CLOV stock. The transaction, which happened on March 3, saw Clinton purchase 100,000 shares for an average cost of $2.52 per share. In total, Clinton’s current transaction amounted to $252,530, according to a Form 4 submitted to the U.S. Securities and Exchange Payment (SEC).

Why Is CLOV Stock Up Today?
Today, CLOV stock is up in response to Clinton’s acquisition, which investors are viewing as a positive signal. Many times, supervisor trading activity similar to this is important to track since insiders frequently have a better sight of a business’s lasting development possibility than retail capitalists.

So, with that said in mind, are various other experts of Clover bullish on the company? In the past one year, insiders have actually acquired 2.2 million shares and marketed 22.9 million shares. That’s an internet of 20.6 million shares sold. This mass expert marketing seems to correlate with CLOV stock’s decline of more than 60% over the past one year.

Still, with Clinton’s recent acquisition, investors are wondering who else is wagering big on Clover Health. Allow’s jump right in.

Who Else Is Betting Big on Clover Health?
As of the fourth quarter, 160 institutional capitalists own shares of CLOV stock. That notes a quarter-0ver-quarter (QOQ) boost of 8.8%. Throughout the period, the complete amount of shares held by institutional investors likewise raised from 105.7 million to 129.8 million, up virtually 23% QOQ. Allow’s have a look at the top 5 institutional investors.

Vanguard has 25.9 million shares or 7.65% ownership. The firm acquired 8.8 million shares throughout Q4.
Greenoaks Resources Allies owns 24.8 million shares or 7.34% possession. The company marketed 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The firm purchased 2.6 million shares throughout Q4.
2 Sigma Investments has 6.6 million shares or 1.95% ownership. The company acquired all 6.6 million shares throughout Q4.
PNC Financial Services (NYSE: PNC) has 6.4 million shares or 1.88% possession. The company marketed 249,850 shares throughout Q4.
Out of the top 5 investors, three funds lowered their placements as well as two funds boosted their settings. Greenoaks Capital Allies had the most notable purchase, as the fund sold concerning 50% of its existing position during Q4. 2 Sigma’s 6.6 million share purchase was additionally noteworthy, as the acquisition placed it among the top 5 investors.

Flenn Burke

Back to top